EMHA Migraine in Women Survey
In 2025, EMHA launched the largest European survey on hormonal migraine. The questionnaire targeted the general population, with 5,400 women screened-positive for migraine, forming the sample of the survey. With oversight from an interdisciplinary Scientific Committee, we set out to understand how hormonal life stages-menstruation, pregnancy, menopause-affect migraine, and how healthcare responds.
The results reveal a clear pattern of need and a clear gap in care.
Download the full report here
The survey sheds light on how hormonal changes influence migraine across women’s lives and highlights important opportunities to improve diagnosis and care. Many women report a clear relationship between the timing and intensity of migraine attacks and their menstrual cycle. At the same time, the overall symptom burden remains high, while only a small proportion of respondents report being satisfied with their current treatment.
Significant gaps persist in both diagnosis and care-seeking. Despite evidence that personalised approaches can improve outcomes, the link between hormones and migraine is still insufficiently discussed in clinical settings.
EMHA calls for urgent action on hormonally related migraine, built on three pillars:
Recognise. Diagnose. Treat.
